Ambest Pharmaceutical (China)

China
Caoxi, Jiangxi, China

Company profile

Ambest Pharmaceutical (China) company profile

Ambest Pharmaceutical (China) is engaged in the manufacturing of large volume injectables, and research, technology transfer and technology services of pharmaceutical products. It currently holds the drug production approvals of monoammonium glycyrrhizinate and cysteine and sodium chloride injection and floium Ginkgo extract and tertram rthypyrazine sodium chloride injection.

Business identity

Operating status
Active
Company type
For Profit

Headquarters

Headquarters
Caoxi, Jiangxi, China
Country code
CN
Continent
Asia

Capital profile

Funding and company signals

Funding stage
M And A
Exited on
2017-03-27

Founders and investors

No public relation records are available.

People at this company

Preview only. Contact details are available after you sign in.

Log in to view people and contact details at this company

Contact information and company affiliations may no longer be accurate. Verify details before reaching out.

Shipment data

Explore detailed shipment data

Sign in to view shipment history, products, suppliers, and trade lanes for this company.

Log in to view shipment data

Shipment records and coverage can change as the dataset is updated.